In vitro antimicrobial activity of rifaximin against enteropathogens causing traveler's diarrhea

Diagnostic Microbiology and Infectious Disease

Volumn 59, Issue 4, 2007, Pages 473-475

  Ruiz, Joaquim ^a   Mensa, Laura ^a   O'Callaghan, Cristina ^a   Pons, Maria J ^a   González, Ana ^a   Vila, Jordi ^b   Gascón, Joaquim ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

EAEC; ETEC; Rifaximin; Shigella sonnei; Traveler's diarrhea

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; NALIDIXIC ACID; RIFAXIMIN; TETRACYCLINE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SHIGELLA SONNEI; TRAVELLER DIARRHEA;

ANTI-INFECTIVE AGENTS; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ENTEROTOXIGENIC ESCHERICHIA COLI; HUMANS; MICROBIAL SENSITIVITY TESTS; RIFAMYCINS; SHIGELLA SONNEI; TRAVEL;

EID: 36549015767     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.07.003     Document Type: Article

References (28)

1. Ahmed A.M., Furuta K., Shimomura K., Kasama Y., and Shimamoto T. Genetic characterization of multidrug resistance in Shigella spp. from Japan. J. Med. Microbiol. 55 (2006) 1685-1691
2. Al-Abri S., Beeching N.J., and Nye F.J. Traveller's diarrhoea. Lancet Infect. Dis. 5 (2005) 349-360
3. Castelli F., Saleri N., Tomasoni L.R., and Carosi G. Prevention and treatment of traveler's diarrhea. Digestion 73 Suppl. 1 (2006) 109-118
4. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement. CLSI document M100-S16 (2006), Clinical and Laboratory Standards Institute, Wayne, PA
5. Ericsson C.D., and Dupont H.L. Rifaximin in the treatment of infectious diarrhea. Chemotherapy 51 Suppl. 1 (2005) 73-80
6. Gascón J. Epidemiology, etiology and pathophysiology of traveler's diarrhea. Digestion 73 Suppl. 1 (2006) 102-108
7. Hart C.A., and Kariuki S. Antimicrobial resistance in developing countries. BMJ 317 (1998) 647-650
8. Huang D.B., and DuPont H.L. Rifaximin-a novel antimicrobial for enteric infections. J. Infect. 50 (2005) 97-106
9. Jiang Z.D., Ke S., Palazzini E., Riopel L., and DuPont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob. Agents Chemother. 44 (2000) 2205-2206
10. Khan W.A., Seas C., Dhar U., Salam M.A., and Bennish M.L. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. Ann. Intern. Med. 126 (1997) 697-703
11. Mandomando I.M., Macete E.V., Ruiz J., Sanz S., Abacassamo F., Vallés X., Sacarlal J., Vila J., Navia M.M., Alonso P.L., and Gascón J. Etiology of diarrhea in children younger than 5 years of age admitted in a rural hospital of southern Mozambique. Am. J. Trop. Med. Hyg. 76 (2007) 522-527
12. Merson M.H., Morris G.K., Sack D.A., Wells J.G., Feeley J.C., Sack R.B., Creech W.B., Kapikian A.Z., and Gangarosa E.J. Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N. Engl. J. Med. 294 (1976) 1299-1305
13. In: Murray P.R., Baron E.J., Pfaller M.A., Tenover F.C., and Yolken R.H. (Eds). Manual of Clinical Microbiology. 6th ed. (1995), ASM Press, Washington, DC
14. Navia M.M., Capitano L., Ruiz J., Vargas M., Urassa H., Schellemberg D., Gascón J., and Vila J. Typing and characterization of the mechanisms of resistance in Shigella sp. isolated from faeces of children in Ifakara (Tanzania). J. Clin. Microbiol. 37 (1999) 3113-3117
15. Niyogi K.S. Shigellosis. J. Microbiol. 43 (2005) 133-143
16. Pazhani G.P., Ramamurthy T., Mitra U., Bhattacharya S.K., and Niyogi S.K. Species diversity and antimicrobial resistance of Shigella spp. isolated between 2001 and 2004 from hospitalized children with diarrhoea in Kolkata (Calcutta), India. Epidemiol. Infect. 133 (2005) 1089-1095
17. Radyowijati A., and Haak H. Improving antibiotic use in low-income countries: an overview of evidence on determinants. Soc. Sci. Med. 57 (2003) 733-744
18. Ruiz J., Gómez J., Navia M.M., Ribera A., Sierra J.M., Marco F., Mensa J., and Vila J. High prevalence of nalidixic acid resistant, ciprofloxacin susceptible phenotype among clinical isolates of Escherichia coli and other Enterobacteriaceae. Diagn. Microbiol. Infect. Dis. 42 (2002) 257-261
19. Ruiz J., Marco F., Oliveira I., Vila J., and Gascón J. Trends in antimicrobial resistance levels among Campylobacter spp. causing traveler's diarrhea. APMIS 115 (2007) 218-224
20. Scrascia M., Forcillo M., Maimone F., and Pazzani C. Susceptibility to rifaximin of Vibrio cholerae strains from different geographical areas. J. Antimicrob. Chemother. 52 (2003) 303-305
21. Sierra J.M., Ruiz J., Navia M.M., Vargas M., Gascon J., and Vila J. In vitro activity of rifaximin over enteropathogens producing traveler's diarrhea. Antimicrob. Agents Chemother. 47 (2001) 643-644
22. Taneja N. Changing epidemiology of shigellosis and emergence of ciprofloxacin-resistant Shigellae in India. Antimicrob. Agents Chemother. 45 (2007) 678-679
23. Vargas M., Gascon J., Gallardo F., Jimenes de Anta M.T., and Vila J. Prevalence of diarrheagenic Escherichia coli strains detected by PCR in patients with travelers' diarrhea. Clin. Microbiol. Infect. 4 (1998) 628-682
24. Vila J., Vargas M., Ruiz J., Espasa M., Pujol M., Corachan M., Jiménez de Anta M.T., and Gascón J. Susceptibility patterns of enteroaggregative Escherichia coli associated to traveller's diarrhoea. Emergence of quinolone resistance. J. Med. Microbiol. 50 (2001) 996-1000
25. Wain J., Hoa N.T., Chinh N.T., Vinh H., Everett M.J., Diep T.S., Day N.P., Solomon T., White N.J., Piddock L.J., and Parry C.M. Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin. Infect. Dis. 25 (1997) 1404-1410
26. Weill F.X., Bertrand S., Guesnier F., Baucheron S., Cloeckaert A., and Grimont P.A. Ciprofloxacin-resistant Salmonella Kentucky in travelers. Emerg. Infect. Dis. 12 (2006) 1611-1612
27. Wilson A., Evans J., Chart H., Cheasty T., Wheeler J.G., Tompkins D., and Smith H.R. Characterisation of strains of enteroaggregative Escherichia coli isolated during the infectious intestinal disease study in England. Eur. J. Epidemiol. 17 (2002) 1125-1130
28. Wiuff C., Lykkesfeldt J., Aarestrup F.M., and Svendsen O. Distribution of enrofloxacin in intestinal tissue and contents of healthy pigs after oral and intramuscular administrations. J. Vet. Pharmacol. Ther. 25 (2002) 335-342